BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1995230)

  • 41. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
    Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validity of the American Thoracic Society and other spirometric algorithms using FVC and forced expiratory volume at 6 s for predicting a reduced total lung capacity.
    Swanney MP; Beckert LE; Frampton CM; Wallace LA; Jensen RL; Crapo RO
    Chest; 2004 Dec; 126(6):1861-6. PubMed ID: 15596685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pilot study of office-based spirometry in patients with systemic lupus erythematosus.
    Mancuso CA; Perna M; Sargent AB; Salmon JE
    Lupus; 2012 Oct; 21(12):1343-50. PubMed ID: 22875652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease].
    Zagdańska R; Grzelewska-Rzymowska I
    Pneumonol Alergol Pol; 2005; 73(2):142-7. PubMed ID: 16756143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abdominal adiposity is an early marker of pulmonary function impairment: Findings from a Mediterranean Italian female cohort.
    Vatrella A; Calabrese C; Mattiello A; Panico C; Costigliola A; Chiodini P; Panico S
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):643-648. PubMed ID: 27107841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interpretation of spirometric tests in asthmatic patients with reduced forced vital capacity.
    Almirall JJ; Páez I
    J Investig Allergol Clin Immunol; 1994; 4(5):258-60. PubMed ID: 7874324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poor interpretation of pulmonary function tests in patients with concomitant decreases in FEV1 and FVC.
    Hong Y; Ra SW; Shim TS; Lim CM; Koh Y; Lee SD; Kim WS; Kim DS; Kim WD; Oh YM
    Respirology; 2008 Jun; 13(4):569-74. PubMed ID: 18410263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Prevalence of COPD in Individuals with Acute Coronary Syndrome: A Spirometry-Based Screening Study.
    Mooe T; Stenfors N
    COPD; 2015 Aug; 12(4):453-61. PubMed ID: 25415235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of symptoms & spirometry in children treated for asthma.
    Anandi S; Tullu MS; Lahiri K
    Indian J Med Res; 2016 Jul; 144(1):124-127. PubMed ID: 27834336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physical activity is not associated with spirometric indices in lung-healthy German youth.
    Smith MP; von Berg A; Berdel D; Bauer CP; Hoffmann B; Koletzko S; Nowak D; Heinrich J; Schulz H
    Eur Respir J; 2016 Aug; 48(2):428-40. PubMed ID: 27009173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional implications of BAL in the presence of restrictive or obstructive lung disease.
    Pedreira WL; de Souza R; Fiks IN; Salge JM; de Carvalho CR
    Respir Med; 2007 Jun; 101(6):1344-9. PubMed ID: 17118639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary function in gastro-oesophageal reflux disease of elderly people.
    Räihä IJ; Ivaska K; Sourander LB
    Age Ageing; 1992 Sep; 21(5):368-73. PubMed ID: 1414675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease.
    Mahler DA; Faryniarz K; Tomlinson D; Colice GL; Robins AG; Olmstead EM; O'Connor GT
    Chest; 1992 Aug; 102(2):395-401. PubMed ID: 1643921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative spirometry and perioperative drug therapy in patients with obstructive pulmonary dysfunction.
    Takiguchi H; Niimi K; Tomomatsu H; Tomomatsu K; Hayama N; Oguma T; Aoki T; Urano T; Asai S; Miyachi H; Abe T; Asano K
    Tokai J Exp Clin Med; 2014 Sep; 39(3):151-7. PubMed ID: 25248432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lung volumes in 4,774 patients with obstructive lung disease.
    Dykstra BJ; Scanlon PD; Kester MM; Beck KC; Enright PL
    Chest; 1999 Jan; 115(1):68-74. PubMed ID: 9925064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decline in annual lung function in workers exposed to asbestos with and without pre-existing fibrotic changes on chest radiography.
    Nakadate T
    Occup Environ Med; 1995 Jun; 52(6):368-73. PubMed ID: 7627312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study). Baseline characteristics of randomized participants.
    Buist AS; Connett JE; Miller RD; Kanner RE; Owens GR; Voelker HT
    Chest; 1993 Jun; 103(6):1863-72. PubMed ID: 8404115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Airway hyperreactivity in subjects with tetraplegia is associated with reduced baseline airway caliber.
    Grimm DR; Chandy D; Almenoff PL; Schilero G; Lesser M
    Chest; 2000 Nov; 118(5):1397-404. PubMed ID: 11083692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.